Haematic antegrade repriming to enhance recovery after cardiac surgery from the perfusionist side

Open Access

Table 5

Minimum global cost estimation.

Unitary cost*	Price ($)	Period	ATT	Cost/patient ($)
RBC transfusion	1183.22	24 h	−47.55%	−562.62
		>24 h to discharge	−33.96%	−401.82
PT transfusion	3457.06	24 h	−28.86%	−977.71
FP transfusion	1608.37	24 h	−10.31%	−165.82
		>24 h to discharge	−3.99%	−64.17
ICU >2d	3500		−16.28%	−569.80
HAR application	0			0
Total amount				−2741.94

Abbreviations: ATT: Average treatment effect on treated, RBC: red blood cells, PT: platelets, FP: fresh plasma, ICU > 2d: intensive care unit costs after the 2nd day of stay. *Overall cost per process was obtained from [36–39].

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.